Redeye: EG7 - Palia adds growth to live portfolio
Redeye updates on EG7 following its Q2-results which were in line with preliminary results. The company reiterates its guidance, suggesting potential for a strong H2 2024, while the acquisition of S6 and Palia improves growth in the live service portfolio.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/